Helen Kaipe
Researcher | Docent
E-mail: helen.kaipe@ki.se
Visiting address: Nobels väg 7, 17165 Solna
Postal address: H5 Laboratoriemedicin, H5 Klin immunologi Kaipe, 141 52 Huddinge
Part of:
- Department of Laboratory Medicine
- Division of Clinical Immunology at Labmed
- Tissue immunology – Research group Helen Kaipe
Articles
- Article: CANCER RESEARCH COMMUNICATIONS. 2024;4(2):460-474Gorchs L; Fernandez-Moro C; Asplund E; Oosthoek M; Solders M; Ghorbani P; Sparrelid E; Rangelova E; Lohr MJ; Kaipe H
- Article: FRONTIERS IN IMMUNOLOGY. 2023;14:1129261Vikberg S; Lindau R; Solders M; Raffetseder J; Budhwar S; Ernerudh J; Tiblad E; Kaipe H
- Article: CANCERS. 2022;14(15):3826Gorchs L; Oosthoek M; Yucel-Lindberg T; Moro CF; Kaipe H
- Article: MOLECULAR IMAGING AND BIOLOGY. 2021;23(6):952-962Friberger I; Jussing E; Han J; Goos JACM; Siikanen J; Kaipe H; Lambert M; Harris RA; Samen E; Carlsten M; Holmin S; Tran TA
- Article: JOURNAL OF REPRODUCTIVE IMMUNOLOGY. 2021;146:103330Lindau R; Vondra S; Spreckels J; Solders M; Svensson-Arvelund J; Berg G; Pollheimer J; Kaipe H; Jenmalm MC; Ernerudh J
- Article: SCIENTIFIC REPORTS. 2020;10(1):17444Gorchs L; Ahmed S; Mayer C; Knauf A; Moro CF; Svensson M; Heuchel R; Rangelova E; Bergman P; Kaipe H
- Article: STEM CELL REPORTS. 2020;14(4):648-662Petrus-Reurer S; Winblad N; Kumar P; Gorchs L; Chrobok M; KathleenWagner A; Bartuma H; Lardner E; Aronsson M; Reyes AP; Andre H; Alici E; Kaipe H; Kvanta A; Lanner F
- Article: METHODS IN MOLECULAR BIOLOGY. 2020;2098:55-70Solders M; Gorchs L; Kaipe H
- Article: AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY. 2019;82(3):e13154Solders M; Lundell A-C; Gorchs L; Gidlof S; Tiblad E; Kaipe H
- Article: FRONTIERS IN IMMUNOLOGY. 2019;10:1300Solders M; Gorchs L; Tiblad E; Gidlof S; Leeansyah E; Dias J; Sandberg JK; Magalhaes I; Lundell A-C; Kaipe H
- Article: FRONTIERS IN IMMUNOLOGY. 2019;10:847Gorchs L; Moro CF; Bankhead P; Kern KP; Sadeak I; Meng Q; Rangelova E; Kaipe H
- Article: FRONTIERS IN IMMUNOLOGY. 2017;8:1861Solders M; Erkers T; Gorchs L; Poiret T; Remberger M; Magalhaes I; Kaipe H
- Article: SCIENTIFIC REPORTS. 2017;7(1):6123Solders M; Gorchs L; Erkers T; Lundell A-C; Nava S; Gidlof S; Tiblad E; Magalhaes I; Kaipe H
- Article: JOURNAL OF LEUKOCYTE BIOLOGY. 2017;101(3):623-632Erkers T; Solders M; Verleng L; Bergstroem C; Stikvoort A; Rane L; Nava S; Ringden O; Kaipe H
- Article: SCIENTIFIC REPORTS. 2017;7:39904Lundell A-C; Nordstrom I; Andersson K; Lundqvist C; Telemo E; Nava S; Kaipe H; Rudin A
- Article: STEM CELLS INTERNATIONAL. 2017;2017:8010961-15Solders M; Gorchs L; Gidlof S; Tiblad E; Lundell A-C; Kaipe H
- Article: CELL TRANSPLANTATION. 2016;25(2):401-410Arnberg F; Lundberg J; Olsson A; Samen E; Jaff N; Jussing E; Dahlen U; Nava S; Axelsson R; Ringden O; Kaipe H; Holmin S
- Article: CYTOTHERAPY. 2015;17(12):1732-1745Sadeghi B; Heshmati Y; Khoein B; Kaipe H; Uzunel M; Walfridsson J; Ringden O
- Article: STEM CELLS AND DEVELOPMENT. 2015;24(12):1471-1482Kaipe H; Carlson L-M; Erkers T; Nava S; Mollden P; Gustafsson B; Qian H; Li X; Hashimoto T; Sadeghi B; Alheim M; Ringden O
- Article: STEM CELLS AND DEVELOPMENT. 2015;24(2):253-263Erkers T; Kaipe H; Nava S; Mollden P; Gustafsson B; Axelsson R; Ringden O
- Article: BONE MARROW TRANSPLANTATION. 2014;49(12):1486-1491Arnberg F; Lundberg J; Kenne E; Jaff N; Mueller P; Nava S; Kaipe H; Ringden O; Holmin S
- Article: STEM CELLS AND DEVELOPMENT. 2013;22(19):2596-2605Erkers T; Nava S; Yosef J; Ringden O; Kaipe H
- Article: STEM CELLS. 2013;31(3):592-601Ringden O; Erkers T; Nava S; Uzunel M; Iwarsson E; Conrad R; Westgren M; Mattsson J; Kaipe H
- Journal article: FRONTIERS IN IMMUNOLOGY. 2013;4Tom E; Silvia N; Jena Y; Olle RN; Helen K
- Article: BONE MARROW TRANSPLANTATION. 2012;47(5):706-715Svahn B-M; Remberger M; Alvin O; Karlsson H; Ringden O
- Article: TRANSPLANTATION AND CELLULAR THERAPY. 2012;18(4):557-564von Bahr L; Sundberg B; Lonnies L; Sander B; Karbach H; Hagglund H; Ljungman P; Gustafsson B; Karlsson H; Le Blanc K; Ringden O
- Article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2012;167(3):543-555Karlsson H; Erkers T; Nava S; Ruhm S; Westgren M; Ringden O
- Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2011;87(6):503-509Ringden O; Remberger M; Dahllof G; Garming-Legert K; Karlsson H; Svenberg P; Uhlin M; Uzunel M; Mattsson J
- Article: TRANSPLANTATION AND CELLULAR THERAPY. 2011;17(11):1688-1697Remberger M; Ackefors M; Berglund S; Blennow O; Dahllof G; Dlugosz A; Garming-Legert K; Gertow J; Gustafsson B; Hassan M; Hassan Z; Hauzenberger D; Hagglund H; Karlsson H; Klingspor L; Kumlien G; Le Blanc K; Ljungman P; Machaczka M; Malmberg K-J; Marschall H-U; Mattsson J; Olsson R; Omazic B; Sairafi D; Schaffer M; Svahn B-M; Svenberg P; Swartling L; Szakos A; Uhlin M; Uzunel M; Watz E; Wernerson A; Wikman A; Wikstrom A-C; Winiarski J; Ringden O
- Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 2011;41(4):1143-1153Karlsson H; Nava S; Remberger M; Hassan Z; Hassan M; Ringden O
- Article: TRANSPLANTATION. 2010;90(9):1022-1029Ringden O; Hassan Z; Karlsson H; Olsson R; Omazic B; Mattsson J; Remberger M
- Article: BLOOD. 2010;115(2):396-407Samarasinghe S; Mancao C; Pule M; Nawroly N; Karlsson H; Brewin J; Openshaw P; Gaspar HB; Veys P; Amrolia PJ
- Article: JOURNAL OF IMMUNOTHERAPY. 2010;33(1):96-105Okas M; Gertow J; Uzunel M; Karlsson H; Westgren M; Karre K; Ringden O; Mattsson J; Uhlin M
- Article: BLOOD. 2009;114(23):4792-4803Brewin J; Mancao C; Straathof K; Karlsson H; Samarasinghe S; Amrolia PJ; Pule M
- Article: JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY. 2009;31(6):456-461Rao K; Rao A; Karlsson H; Jagani M; Veys P; Amrolia PJ
- Article: CLINICAL AND EXPERIMENTAL ALLERGY. 2009;39(5):662-670Lundell A-C; Hesselmar B; Nordstrom I; Saalman R; Karlsson H; Lindberg E; Aberg N; Adlerberth I; Wold AE; Rudin A
- Article: TRANSPLANTATION. 2009;87(4):467-472Uhlin M; Okas M; Karlsson H; Gertow J; Henningsohn L; Ringden O; Karre K; Levitsky V; Mattsson J
- Article: BLOOD. 2008;112(3):532-541Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responsesKarlsson H; Samarasinghe S; Ball LM; Sundberg B; Lankester AC; Dazzi F; Uzunel M; Rao K; Veys P; Le Blanc K; Ringden O; Amrolia PJ
- Article: BONE MARROW TRANSPLANTATION. 2008;41(9):785-790Barkholt L; Remberger M; Hassan Z; Fransson K; Omazic B; Svahn B-M; Karlsson H; Brune M; Hassan M; Mattsson J; Ringden O
- Article: JOURNAL OF IMMUNOTHERAPY. 2007;30(5):544-556Karlsson H; Brewin J; Kinnon C; Veys P; Amrolia PJ
- Article: CLINICAL AND EXPERIMENTAL ALLERGY. 2007;37(1):62-71Lundell A-C; Adlerberth I; Lindberg E; Karlsson H; Ekberg S; Aberg N; Saalman R; Hock B; Steinkasserer A; Hesselmar B; Wold AE; Rudin A
- Article: ALLERGY. 2005;60(9):1184-1191Lundell ACA; Grindebacke H; Karlsson H; Seppälä U; Rudin A
- Article: INFLAMMATION. 2004;28(3):159-168Bjersing JL; Tarkowski A; Kandimalla ER; Karlsson H; Agrawal S; Collins LV
- Article: INFECTION AND IMMUNITY. 2004;72(5):2671-2678Karlsson H; Larsson P; Wold AE; Rudin A
- Article: INFECTION AND IMMUNITY. 2002;70(12):6688-6696Karlsson H; Hessle C; Rudin A
- Article: IMMUNOLOGY. 2002;106(2):190-199Wing K; Ekmark A; Karlsson H; Rudin A; Suri-Payer E
- Show more
All other publications
- Preprint: BIORXIV. 2024Strunz B; Ivarsson MA; Sun D; Ziegenhain C; Crona-Guterstam Y; Solders M; Björklund A; Marquardt N; Kaipe H; Flöter-Rådestad A; Gidlöf S; Brännström M; Björkström NK
- Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2024Gorchs L; Fernández-Moro C; Asplund E; Oosthoek M; Solders M; Ghorbani P; Sparrelid E; Rangelova E; Löhr MJ; Kaipe H
- Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2024Gorchs L; Fernández-Moro C; Asplund E; Oosthoek M; Solders M; Ghorbani P; Sparrelid E; Rangelova E; Löhr MJ; Kaipe H
- Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2024Gorchs L; Fernández-Moro C; Asplund E; Oosthoek M; Solders M; Ghorbani P; Sparrelid E; Rangelova E; Löhr MJ; Kaipe H
- Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2024Gorchs L; Fernández-Moro C; Asplund E; Oosthoek M; Solders M; Ghorbani P; Sparrelid E; Rangelova E; Löhr MJ; Kaipe H
- Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2024Gorchs L; Fernández-Moro C; Asplund E; Oosthoek M; Solders M; Ghorbani P; Sparrelid E; Rangelova E; Löhr MJ; Kaipe H
- Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2024Gorchs L; Fernández-Moro C; Asplund E; Oosthoek M; Solders M; Ghorbani P; Sparrelid E; Rangelova E; Löhr MJ; Kaipe H
- Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2024Gorchs L; Fernández-Moro C; Asplund E; Oosthoek M; Solders M; Ghorbani P; Sparrelid E; Rangelova E; Löhr MJ; Kaipe H
- Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2024Gorchs L; Fernández-Moro C; Asplund E; Oosthoek M; Solders M; Ghorbani P; Sparrelid E; Rangelova E; Löhr MJ; Kaipe H
- Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2024Gorchs L; Fernández-Moro C; Asplund E; Oosthoek M; Solders M; Ghorbani P; Sparrelid E; Rangelova E; Löhr MJ; Kaipe H
- Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2024Gorchs L; Fernández-Moro C; Asplund E; Oosthoek M; Solders M; Ghorbani P; Sparrelid E; Rangelova E; Löhr MJ; Kaipe H
- Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2024Gorchs L; Fernández-Moro C; Asplund E; Oosthoek M; Solders M; Ghorbani P; Sparrelid E; Rangelova E; Löhr MJ; Kaipe H
- Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2024Gorchs L; Fernández-Moro C; Asplund E; Oosthoek M; Solders M; Ghorbani P; Sparrelid E; Rangelova E; Löhr MJ; Kaipe H
- Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2024Gorchs L; Fernández-Moro C; Asplund E; Oosthoek M; Solders M; Ghorbani P; Sparrelid E; Rangelova E; Löhr MJ; Kaipe H
- Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2024Gorchs L; Fernández-Moro C; Asplund E; Oosthoek M; Solders M; Ghorbani P; Sparrelid E; Rangelova E; Löhr MJ; Kaipe H
- Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2024Gorchs L; Fernández-Moro C; Asplund E; Oosthoek M; Solders M; Ghorbani P; Sparrelid E; Rangelova E; Löhr MJ; Kaipe H
- Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2024Gorchs L; Fernández-Moro C; Asplund E; Oosthoek M; Solders M; Ghorbani P; Sparrelid E; Rangelova E; Löhr MJ; Kaipe H
- Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2024Gorchs L; Fernández-Moro C; Asplund E; Oosthoek M; Solders M; Ghorbani P; Sparrelid E; Rangelova E; Löhr MJ; Kaipe H
- Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2024Gorchs L; Fernández-Moro C; Asplund E; Oosthoek M; Solders M; Ghorbani P; Sparrelid E; Rangelova E; Löhr MJ; Kaipe H
- Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2024Gorchs L; Fernández-Moro C; Asplund E; Oosthoek M; Solders M; Ghorbani P; Sparrelid E; Rangelova E; Löhr MJ; Kaipe H
- Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2024Gorchs L; Fernández-Moro C; Asplund E; Oosthoek M; Solders M; Ghorbani P; Sparrelid E; Rangelova E; Löhr MJ; Kaipe H
- Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2024Gorchs L; Fernández-Moro C; Asplund E; Oosthoek M; Solders M; Ghorbani P; Sparrelid E; Rangelova E; Löhr MJ; Kaipe H
- Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2024Gorchs L; Fernández-Moro C; Asplund E; Oosthoek M; Solders M; Ghorbani P; Sparrelid E; Rangelova E; Löhr MJ; Kaipe H
- Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2024Gorchs L; Fernández-Moro C; Asplund E; Oosthoek M; Solders M; Ghorbani P; Sparrelid E; Rangelova E; Löhr MJ; Kaipe H
- Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2024Gorchs L; Fernández-Moro C; Asplund E; Oosthoek M; Solders M; Ghorbani P; Sparrelid E; Rangelova E; Löhr MJ; Kaipe H
- Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2024Gorchs L; Fernández-Moro C; Asplund E; Oosthoek M; Solders M; Ghorbani P; Sparrelid E; Rangelova E; Löhr MJ; Kaipe H
- Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2024Gorchs L; Fernández-Moro C; Asplund E; Oosthoek M; Solders M; Ghorbani P; Sparrelid E; Rangelova E; Löhr MJ; Kaipe H
- Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2024Gorchs L; Fernández-Moro C; Asplund E; Oosthoek M; Solders M; Ghorbani P; Sparrelid E; Rangelova E; Löhr MJ; Kaipe H
- Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2024Gorchs L; Fernández-Moro C; Asplund E; Oosthoek M; Solders M; Ghorbani P; Sparrelid E; Rangelova E; Löhr MJ; Kaipe H
- Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2024Gorchs L; Fernández-Moro C; Asplund E; Oosthoek M; Solders M; Ghorbani P; Sparrelid E; Rangelova E; Löhr MJ; Kaipe H
- Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2024Gorchs L; Fernández-Moro C; Asplund E; Oosthoek M; Solders M; Ghorbani P; Sparrelid E; Rangelova E; Löhr MJ; Kaipe H
- Corrigendum: MOLECULAR IMAGING AND BIOLOGY. 2022;24(3):510Friberger I; Jussing E; Han J; Goos JACM; Siikanen J; Kaipe H; Lambert M; Harris RA; Samen E; Carlsten M; Holmin S; Tran TA
- Review: CHINESE CLINICAL ONCOLOGY. 2022;11(1):4Rangelova E; Kaipe H
- Review: CANCERS. 2021;13(12):2995Gorchs L; Kaipe H
- Review: FRONTIERS IN IMMUNOLOGY. 2020;11:1788Kaipe H; Raffetseder J; Ernerudh J; Solders M; Tiblad E
- Review: METHODS IN MOLECULAR BIOLOGY. 2020;2098:3-21Magalhaes I; Solders M; Kaipe H
- Conference publication: JOURNAL OF REPRODUCTIVE IMMUNOLOGY. 2018;128:54Lindau R; Vondra S; Spreckels J; Solders M; Svensson-Arvelund J; Berg G; Pollheimer J; Knoefler M; Jenmalm MC; Kaipe H; Ernerudh J
- Conference publication: INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 2018;59(9)Petrus-Reurer S; Gorchs L; Chrobok M; Wagner AK; Lardner E; Bartuma H; Aronsson M; Westman S; Alici E; Kaipe H; Lanner F; Kvanta AP
- Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2017;86(4):302Solders M; Gorchs L; Erkers T; Lundell A-C; Nava S; Gidlof S; Tiblad E; Magalhaes I; Kaipe H
- Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2017;86(4):308-309Gorchs L; Paraschoudi G; Meng Q; Bergman P; Maeurer M; Kaipe H
- Conference publication: EUROPEAN JOURNAL OF IMMUNOLOGY. 2016;46:845Erkers T; Solders M; Verlang L; Bergstrom C; Stikvoort A; Rane L; Nava S; Ringden O; Kaipe H
- Conference publication: EUROPEAN JOURNAL OF IMMUNOLOGY. 2016;46:844-845Erkers T; Solders M; Verleng L; Nava S; Mollden P; Mattsson J; Ringden O; Lundell A-C; Kaipe H
- Conference publication: EUROPEAN JOURNAL OF IMMUNOLOGY. 2016;46:50Solders M; Gorchs L; Erkers T; Nava S; Ringden O; Magalhaes I; Kaipe H
- Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2016;22(3):S48Ringden O; Solders M; Baygan A; Remberger M; Erkers T; Nava S; Gustavsson B; Winiarski J; Westgren M; Sadeghi B; Mattsson J; Kaipe H
- Conference publication: BONE MARROW TRANSPLANTATION. 2016;51:S377Solders M; Baygan A; Remberger M; Erkers T; Nava S; Gustafsson B; Winiarski J; Sadeghi B; Kaipe H; Ringden O
- Conference publication: BONE MARROW TRANSPLANTATION. 2016;51:S319Aronsson-Kurttila W; Baygan A; Remberger M; Solders M; Erkers T; Nava S; Khoein B; Sadeghi B; Kaipe H; Ringden O
- Conference publication: BONE MARROW TRANSPLANTATION. 2015;50:S321-S322Erkers T; Bergstrom C; Nava S; Mollden P; Kaipe H
- Conference publication: BONE MARROW TRANSPLANTATION. 2015;50:5572Feldreich NG; Kaipe H; Ringden O; Omazic B
- Conference publication: BONE MARROW TRANSPLANTATION. 2015;50:S24Solders M; Remberger M; Erkers T; Nava S; Mollden P; Mattsson J; Kaipe H; Ringden O
- Conference publication: BONE MARROW TRANSPLANTATION. 2015;50:S315-S316Ringden O; Solders M; Erkers T; Nava S; Mollden P; Khoein B; Aronsson-Kurttila W; Mohmand S; Remberger M; Westgren M; Mattsson J; Sadeghi B; Kaipe H
- Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2015;21(2):S349-S350Solders M; Erkers T; Remberger M; Nava S; Mollden P; Mattsson J; Kaipe H; Ringden O
- Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2015;21(2):S149Ringden O; Solders M; Erkers T; Nava S; Mollden P; Khoein B; Baygan A; Aronsson-Kurttila W; Mohmand S; Remberger M; Westgren M; Mattsson J; Sadeghi B; Kaipe H
- Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2015;21(2):S147Erkers T; Kaipe H; Nava S; Mollden P; Gustafsson B; Axelsson R; Ringden O
- Review: BONE MARROW TRANSPLANTATION. 2014;49(6):737-743Kaipe H; Erkers T; Sadeghi B; Ringden O
- Conference publication: BONE MARROW TRANSPLANTATION. 2014;49:S131-S132Kaipe H; Carlson L-M; Erkers T; Nava S; Mollden P; Alheim M; Ringden O
- Conference publication: BONE MARROW TRANSPLANTATION. 2014;49:S126-S127Erkers T; Kaipe H; Nava S; Gustafsson B; Jansson B; Axelsson R; Ringden O
- Conference publication: BONE MARROW TRANSPLANTATION. 2014;49:S128Sadeghi B; Erkers T; Heshmati Y; Magalhaes I; Nava S; Mollden P; Walfridsson J; Kaipe H; Ringden O
- Conference publication: BONE MARROW TRANSPLANTATION. 2013;48:S73Erkers T; Nava S; Yosef J; Ringden O; Kaipe H
- Conference publication: BONE MARROW TRANSPLANTATION. 2013;48:S175-S176Kaipe H; Erkers T; Nava S; Uzunel M; Iwarsson E; Conrad R; Westgren M; Mattsson J; Ringden O
- Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2013;19(2):S141-S142Ringden O; Erkers T; Nava S; Uzunel M; Iwarsson E; Conrad R; Westgren M; Mattsson J; Kaipe H
- Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2012;18(2):S264Erkers T; Nava S; Ruhm S; Westgren M; Ringden O; Karlsson H
- Conference publication: TRANSPLANTATION AND CELLULAR THERAPY. 2012;18(2):S339Svahn B-M; Remberger M; Alvin O; Karlsson H; Ringden O
- Conference publication: BONE MARROW TRANSPLANTATION. 2011;46:S167-S168Ringden O; Ackefors M; Berglund S; Blennow O; Dahllof G; Dlugosz A; Garming-Legert K; Gertow J; Gustafsson B; Hassan M; Hassan Z; Hauzenberger D; Hagglund H; Karlsson H; Klingspor L; Kumlien G; Le Blanc K; Ljungman P; Machaczka M; Marschall H-U; Mattsson J; Olsson R; Omazic B; Sairafi D; Schaffer M; Svahn B-M; Svenberg P; Swartling L; Szakos A; Uhlin M; Uzunel M; Watz E; Wernerson A; Wikman A; Wikstrom A-C; Winiarski J; Remberger M
- Conference publication: BONE MARROW TRANSPLANTATION. 2011;46:S241-S242Karlsson H; Ruhm S; Nava S; Ringden O
- Review: BRITISH JOURNAL OF HAEMATOLOGY. 2009;147(5):614-633Ringden O; Karlsson H; Olsson R; Omazic B; Uhlin M
- Editorial comment: LANCET ONCOLOGY. 2009;10(5):440-442Ringden O; Karlsson H; Omazic B
- Conference publication: BONE MARROW TRANSPLANTATION. 2009;43:S51-S52Karlsson H; Nava S; Remberger M; Hassan Z; Hassan M; Ringden O
- Conference publication: BONE MARROW TRANSPLANTATION. 2009;43:S14-S15Uzunel M; Kearsley S; Nava S; Ruhm S; Remberger M; Karlsson H
- Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2009;15(2):127Karlsson H; Nava S; Remberger M; Hassan Z; Hassan M; Ringden O
- Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2009;15(2):130-131Okas M; Gertow J; Uzunel M; Karlsson H; Uzunel M; Ringden O; Mattsson J; Ublin M
- Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2008;14(2):48-49Karlsson H; Samarasinghe S; Ball L; Sundberg B; Lankester AC; Dazzi F; Rao K; Veys P; Le Blanc K; Ringden O; Amrolia PJ
- Conference publication: TRANSPLANTATION AND CELLULAR THERAPY. 2007;13(2):21Samarasinghe S; Karlsson H; Nawroly N; Openshaw P; Veys P; Amrolia P
- Conference publication: TRANSPLANTATION AND CELLULAR THERAPY. 2007;13(2):15Rao K; Rao A; Karlsson H; Veys P; Amrolia P
- Conference publication: ALLERGY. 2002;57:154Grindebacke H; Karlsson H; Rudin A
- Conference publication: ALLERGY. 2002;57:128Karlsson H; Hessle C; Rudin A
- Show more
Grants
- Swedish Research Council1 January 2023 - 31 December 2026Infection with Rift Valley fever virus (RVFV) is associated with miscarriage in humans and cause mass abortions in livestock. The candidate RVFV vaccine strains MP12 and clone 13, both with a non-functional virulence RVFV NSs-gene, still have teratogenic effects. Virus infection pathways in the fetus and host protective mechanisms, e.g. by the innate immune system, are poorly understood. Thus, there is a major gap in the field in understanding how viruses in general, and RVFV, are transmitted from mother to fetus. We will determine RVFV tropism and the inflammatory response in human placental cells for wild-type and NSs deleted RVFV. Both in early-stage and late-stage human placental cells, we will study the infection process, antiviral and cytokine response, as well as gene expression by single cell RNA sequencing. In addition, we will use our assays to study other vertically transmitted mosquito-borne viruses. RVFV infection during pregnancy will also be characterized in a mouse model. In preliminary studies, we have established 2D and 3D-human stem cell cultures, and we show that trophoblast cell lines and human placental stem cells are infected by RVFV ,and cause a pro-inflammatory cytokine response. Our research will provide novel information on pathogenesis of vertically transmitted RVFV and add to the general understanding of fetal infections for other viruses. RVFV is a prioritized disease listed by WHO for urgent research and development of counteraction.
- Swedish Research Council1 January 2020 - 31 December 2022
- Increased understanding of how fibroblasts in pancreatic cancer affect T cells and MAIT cells - effects of reprogramming of fibroblasts to reduce tumor growthSwedish Cancer Society1 January 2018Pancreatic cancer is one of the most aggressive types of cancer. The high mortality is partly due to the fact that the tumor is often resistant to chemotherapy, which leads to metastasis. Around the tumor, a thick layer of connective tissue cells, fibroblasts, is formed, which can prevent chemotherapy and own immune cells from reaching out to kill the tumor cells. Researchers have studied how fibroblasts interact with tumor cells, which have shown that they can support tumor cell growth. Less is known about how fibroblasts in tumors affect immune cells, such as T cells and mucosal associated invariate T (MAIT) cells, and how their activity is regulated. The body's own immune system has the potential to kill cancer cells, but the environment in the tumor can inhibit the function of the immune cells. We study how the functions of T cells and MAIT cells are affected by fibroblasts in pancreatic tumors. We investigate the expression of the receptors on T cells that so-called checkpoint inhibitors bind to, and how fibroblasts affect T cells and the ability of MAIT cells to migrate. Vitamin D and A metabolites can suppress the activation of cancer fibroblasts, which could inhibit tumor growth, and we study how these substances regulate immune cells. We also investigate how MAIT cells are reconstituted after an allogeneic stem cell transplant. Immunotherapy treatment has proven effective in some types of cancer, but so far, few advances have been made in pancreatic cancer. Reprogramming of fibroblasts' activation with vitamin D metabolites has proven effective in animal models, but is still little known about how they interact with human immune cells. An increased understanding of how fibroblasts in the tumor regulate immune cells could lead to new immunotherapies being developed in the long term.
- Cells from placenta as treatment for severe inflammatory complications following allogeneic stem cell transplantation and other cancer treatmentSwedish Cancer Society1 January 2017Allogeneic stem cell transplantation is an established treatment for leukemia, but despite major advances, many patients suffer from severe complications. One of the most common causes of these problems is that the patient's tissues are perceived as foreign to the new immune system, which can lead to the body's own cells being attacked, a so-called graft-versus-host (GvH) reaction. This condition can be life-threatening. We want to cure GvH and other severe complications after stem cell transplantation, and study whether placental and fetal cells from a fully-fledged pregnancy can inhibit this type of inflammation. In the fetus, there are immune-suppressing cells, decidual stromal cells, which prevent the mother's immune system from repelling the child. Fetal membranes have been used for burns, indicating that they also have a healing ability. In the laboratory, we investigate how decidual stromal cells affect the immune system's cells and try to identify the properties that the cells use to suppress inflammation, and how we can best utilize this phenomenon. We treat stem cell transplanted patients who are affected by GvH or other lesions with decidual stromal cells, and map the effects of cell therapy on the immune system and injury counts. We have so far treated about 50 patients with decidula stromal cells, most of them for GvH, but also for bleeding and lung damage. Many patients have responded well to the treatment and have been wholly or partially cured from these conditions. We hope that our research will lead to a better understanding of how the cells' capacity can be optimized for treatment in transplant-related complications and inflammation. By extension, it would lead to improved survival and quality of life for patients with leukemia, but also for patients with other types of cancer who suffered from treatment-related problems, such as radiation injuries.
- Swedish Research Council1 January 2016 - 31 December 2018
- Cells from placenta as treatment for severe inflammatory complications following allogeneic stem cell transplantation and other cancer treatmentSwedish Cancer Society1 January 2015Allogeneic stem cell transplantation is an established treatment for leukemia, but despite major advances, many patients suffer from severe complications. One of the most common causes of these problems is that the patient's tissues are perceived as foreign to the new immune system, which can lead to the body's own cells being attacked, a so-called graft-versus-host (GvH) reaction. This condition can be life-threatening. We want to cure GvH and other severe complications after stem cell transplantation, and study whether placental and fetal cells from a fully-fledged pregnancy can inhibit this type of inflammation. In the fetus, there are immune-suppressing cells, decidual stromal cells, which prevent the mother's immune system from repelling the child. Fetal membranes have been used for burns, indicating that they also have a healing ability. In the laboratory, we investigate how decidual stromal cells affect the immune system's cells and try to identify the properties that the cells use to suppress inflammation, and how we can best utilize this phenomenon. We treat stem cell transplanted patients who are affected by GvH or other lesions with decidual stromal cells, and map the effects of cell therapy on the immune system and injury counts. We have so far treated about 50 patients with decidula stromal cells, most of them for GvH, but also for bleeding and lung damage. Many patients have responded well to the treatment and have been wholly or partially cured from these conditions. We hope that our research will lead to a better understanding of how the cells' capacity can be optimized for treatment in transplant-related complications and inflammation. By extension, it would lead to improved survival and quality of life for patients with leukemia, but also for patients with other types of cancer who suffered from treatment-related problems, such as radiation injuries.
- Cells from placenta as treatment for severe inflammatory complications following allogeneic stem cell transplantation and other cancer treatmentSwedish Cancer Society1 January 2014Allogeneic stem cell transplantation is an established treatment for leukemia, but despite major advances, many patients suffer from severe complications. One of the most common causes of these problems is that the patient's tissues are perceived as foreign to the new immune system, which can lead to the body's own cells being attacked, a so-called graft-versus-host (GvH) reaction. This condition can be life-threatening. We want to cure GvH and other severe complications after stem cell transplantation, and study whether placental and fetal cells from a fully-fledged pregnancy can inhibit this type of inflammation. In the fetus, there are immune-suppressing cells, decidual stromal cells, which prevent the mother's immune system from repelling the child. Fetal membranes have been used for burns, indicating that they also have a healing ability. In the laboratory, we investigate how decidual stromal cells affect the immune system's cells and try to identify the properties that the cells use to suppress inflammation, and how we can best utilize this phenomenon. We treat stem cell transplanted patients who are affected by GvH or other lesions with decidual stromal cells, and map the effects of cell therapy on the immune system and injury counts. We have so far treated about 50 patients with decidula stromal cells, most of them for GvH, but also for bleeding and lung damage. Many patients have responded well to the treatment and have been wholly or partially cured from these conditions. We hope that our research will lead to a better understanding of how the cells' capacity can be optimized for treatment in transplant-related complications and inflammation. By extension, it would lead to improved survival and quality of life for patients with leukemia, but also for patients with other types of cancer who suffered from treatment-related problems, such as radiation injuries.
Employments
- Researcher, Department of Laboratory Medicine, Karolinska Institutet, 2011-
Degrees and Education
- Docent, Karolinska Institutet, 2013